Products - Systemic lupus erythematosus | Topic | NICE

Showing 1 product

Date | Title

Status: In consultationRemove ‘Status: In consultation’ filter

Obinutuzumab for treating serologically active extra-renal lupus [ID6670]
Status:
In development | In consultation
Programme:
Technology appraisal guidance
Consultation end date:
23 March 2026
Expected publication date:
TBC